Your browser doesn't support javascript.
loading
A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A.
Shima, Midori; Amano, Kagehiro; Ogawa, Yoshiyuki; Yoneyama, Koichiro; Ozaki, Ryoto; Kobayashi, Ryota; Sakaida, Emiko; Saito, Makoto; Okamura, Takashi; Ito, Toshihiro; Hattori, Norimichi; Higasa, Satoshi; Suzuki, Nobuaki; Seki, Yoshinobu; Nogami, Keiji.
Afiliação
  • Shima M; Thrombosis and Hemostasis Research Center, Nara Medical University, Kashihara, Japan; Department of Pediatrics, Nara Medical University, Kashihara, Japan. Electronic address: mshima@naramed-u.ac.jp.
  • Amano K; Department of Laboratory Medicine, Tokyo Medical University Hospital, Tokyo, Japan.
  • Ogawa Y; Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Yoneyama K; Chugai Pharmaceutical Co Ltd, Tokyo, Japan.
  • Ozaki R; Chugai Pharmaceutical Co Ltd, Tokyo, Japan.
  • Kobayashi R; Chugai Pharmaceutical Co Ltd, Tokyo, Japan.
  • Sakaida E; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Saito M; Blood Disorders Center, Aiiku Hospital, Sapporo, Japan.
  • Okamura T; Department of Hematology, St. Mary's Hospital, Kurume, Japan.
  • Ito T; Department of Infectious Diseases, National Hospital Organization Sendai Medical Center, Sendai, Japan.
  • Hattori N; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Higasa S; Department of Hematology, Hyogo College of Medicine Hospital, Nishinomiya, Japan.
  • Suzuki N; Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Seki Y; Department of Hematology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minami-uonuma, Japan.
  • Nogami K; Department of Pediatrics, Nara Medical University, Kashihara, Japan.
J Thromb Haemost ; 21(3): 534-545, 2023 03.
Article em En | MEDLINE | ID: mdl-36696195

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Hemofilia A Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Hemofilia A Idioma: En Ano de publicação: 2023 Tipo de documento: Article